Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 9/29/21 → 7/18/26 |
Financiación
- CNS Pharmaceuticals Incorporated: 209.595,00 US$
A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV)
- Villano, PhD, John (PI)